The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company. Looking further, we note that the PEG ratio for the MRNA stock currently stands at 3.20, and the current price level is 2.36% off its SMA20 and 10.26% from its 50-day simple moving average.
https://stocksregister.com/2021/09/27/is-this-the-best-time-to-buy-moderna-inc-nasdaq-mrna-stock/

